Professor
School of Pharmaceutical Sciences at Ribeirao Preto
University of Sao Paulo
Ribeirao Preto, Brazil
http://www.qhetem.com
He completed his degree in pharmacy in 1998 at Universidade Federal do Rio de Janeiro (UFRJ); in 2005, he received a Ph.D. degree in Natural Product Chemistry from Núcleo de Pesquisa de Produtos Naturais (NPPN) at the UFRJ. Currently, is an associate professor at School of Pharmaceutical Sciences at Ribeirão Preto, Universidade de São Paulo.
He is a non-EU member of Chemistry and Molecular Sciences and Technologies (CMST) Co-operation in Science and Technology (COST) Action TD0905, Epigenetics: Bench to Bedside, a scientific activity in the European Union (EU), which aims at integration of the scientific and technological developments across European countries. Since 2013, he is the first secretary of the Brazilian Association of Pharmaceutical Science, and since 2014, he is an active member of IUPAC’s subcommittee on Drug Discovery and Development.
He works in the fields of medicinal chemistry, chemical biology, and heterocycle synthesis, aiming to explore several targets for the discovery of novel bioactive compounds. His interested is mainly focused on heterocyclic chemistry, trying to develop new scaffolds as chemical or fluorescent probes. Regarding neglected diseases, he is focusing on epigenetic targets and DHODH, trying to improve the understanding of biochemical processes by using molecular tools and chemical probes to find new chemical space for drug discovery. He is currently coordinating a collaborative project with GSK (FAPESP/GSK call) targeting epigenetic to fight neglected diseases.
